Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

The bone & joint journal·2026
Same author

A subset of high-grade sarcomas with myogenic differentiation are associated with recurrent FGFR fusions.

The journal of pathology. Clinical research·2026
Same author

Recommendations for Radiation Treatment in Pediatric Patients With Metastatic Rhabdomyosarcoma: Expert Consensus From the International Soft Tissue SaRcoma ConsorTium (INSTRuCT).

Practical radiation oncology·2026
Same author

Does Longitudinal Targeted Panel Sequencing Provide Clinically Relevant Information in Translocation-Associated Sarcomas?

JCO precision oncology·2026
Same author

Bone Cancers in the Philippines: Outcomes, Challenges, and Improvements.

JCO global oncology·2026
Same author

Soft tissue reporting and data system (soft tissue-RADS): framework for radiologists specializing in imaging of musculoskeletal tumors and tumor-like lesions.

Skeletal radiology·2026
Same journal

Childhood Opportunity Index and Severity at Diagnosis of Developmental Dysplasia of the Hip.

The Journal of the American Academy of Orthopaedic Surgeons·2026
Same journal

Management of Intraoperative Fractures During Primary Direct Anterior Total Hip Arthroplasty.

The Journal of the American Academy of Orthopaedic Surgeons·2026
Same journal

Sports Medicine Patients Accurately Predict Their Pain Tolerance.

The Journal of the American Academy of Orthopaedic Surgeons·2026
Same journal

Advocacy for Medical Students Applying to Orthopaedic Surgery: A Practical Guide for Attending Physicians.

The Journal of the American Academy of Orthopaedic Surgeons·2026
Same journal

Bridging the Gap: Social Media as an Untapped Tool in Orthopaedic Trauma Fellowship Recruitment.

The Journal of the American Academy of Orthopaedic Surgeons·2026
Same journal

Surgical Fixation Versus Cast Immobilization for Adults With Bicortical Scaphoid Fractures: A Target Trial Emulation of the SWIFFT Trial.

The Journal of the American Academy of Orthopaedic Surgeons·2026
See all related articles

Related Experiment Video

Updated: Sep 19, 2025

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.8K

Orthopaedic Implant-Associated Rhabdomyosarcoma.

Danielle E Brown1, Carla Saoud, Cristina R Antonescu

  • 1From the Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY (Brown, Bartlett, and Morris), the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY (Saoud and Antonescu), and the Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY (Wexler).

The Journal of the American Academy of Orthopaedic Surgeons
|June 6, 2025
PubMed
Summary
This summary is machine-generated.

Orthopaedic metallic implants are rarely associated with soft-tissue sarcoma, specifically high-grade sclerosing rhabdomyosarcoma. Genetic analysis revealed no significant differences between implant-associated and non-implant-associated tumors.

More Related Videos

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.9K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

10.0K

Related Experiment Videos

Last Updated: Sep 19, 2025

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.8K
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.9K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

10.0K

Area of Science:

  • Orthopaedic surgery
  • Oncology
  • Genetics

Background:

  • Metallic implants are common in orthopaedic surgery.
  • Carcinogenic properties of implants are suspected but rarely documented.
  • This study investigates soft-tissue sarcomas adjacent to orthopaedic implants.

Purpose of the Study:

  • To identify and characterize soft-tissue sarcomas arising adjacent to orthopaedic implants.
  • To compare genetic profiles of implant-associated sarcomas with non-implant-associated sarcomas.
  • To raise physician awareness of this rare diagnosis.

Main Methods:

  • Retrospective review of soft-tissue sarcomas treated at an institution.
  • Identification of tumors adjacent to orthopaedic implants.
  • Collection of clinical, therapeutic, and outcome data.
  • Genetic testing of implant-associated and control tumors.

Main Results:

  • Four cases of high-grade sclerosing rhabdomyosarcoma adjacent to implants were identified.
  • Median time from implant placement to diagnosis was 19 years.
  • All tumors exhibited a MYOD1 mutation; no significant genetic differences were found compared to control tumors.
  • Outcomes varied, with some patients achieving disease-free status and others succumbing to metastatic disease.

Conclusions:

  • No genetic distinctions were found between implant-associated and non-implant-associated rhabdomyosarcomas.
  • The role of metallic implants in tumorigenesis requires further investigation.
  • Clinicians should consider implant-associated sarcoma in patients with new masses near long-standing orthopaedic implants.